A Normal PaCO2 in a Patient Who Cannot Finish a Sentence
A 22-year-old woman with asthma since childhood presents with 8 hours of worsening wheeze after a viral upper respiratory infection. She has used her albuterol inhaler more than 20 times today and has not slept. She can speak only in single words, is sitting forward and tripoding, and has diffuse inspiratory and expiratory wheeze with markedly prolonged expiration. Respiratory rate is 34/min, heart rate 128/min, oxygen saturation 89% on room air, and peak expiratory flow is 35% of her personal best. Arterial blood gas on room air: pH 7.44, PaCO2 40 mmHg, PaO2 61 mmHg, bicarbonate 26 mEq/L. Continuous nebulized albuterol/ipratropium and intravenous corticosteroids have just been started. She has no fever or focal infiltrate.
1. The team is reassured because the PaCO2 is 40 mmHg and the pH is normal. Explain why this reading is alarming rather than reassuring.
Read the worked answer
In acute asthma the patient hyperventilates, so a normal or rising PaCO2 is a sign of impending respiratory failure, not of stability.
Reasoning step by step: bronchospasm and mucus plugging cause widespread V/Q mismatch and increased dead space, so the patient must increase minute ventilation substantially just to keep the PaCO2 normal. A normal PaCO2 in a tachypneic asthmatic means the patient is no longer able to increase minute ventilation enough to match the dead space - i.e., she is tiring. The progression is: low PaCO2 (early) → normal PaCO2 (fatigue) → rising PaCO2 (failure), with acidosis following only late.
A pH of 7.44 is at the very top of normal; a mild respiratory alkalosis has been blown off. Combined with her inability to speak in sentences, accessory muscle use, silent chest risk, and PEF at 35%, this is a picture of near-fatal asthma requiring ICU-level monitoring and preparation for ventilatory support, not observation.
2. Explain the mechanism by which severe hyperinflation and prolonged expiration could produce hypotension, and what it implies for the decision to intubate.
Read the worked answer
The mechanism is dynamic hyperinflation with auto-PEEP (intrinsic PEEP). Severe expiratory flow limitation means the patient cannot exhale fully before the next breath, so air stacks up and intrathoracic pressure rises throughout the respiratory cycle, not just during exhalation.
Consequences:
- Reduced venous return because the high intrathoracic pressure impedes filling of the right heart, lowering stroke volume and blood pressure (pulsus paradoxus is the bedside manifestation).
- Increased work of breathing and mechanical disadvantage of the diaphragm, which promotes fatigue.
- Barotrauma risk.
Implication for intubation: positive-pressure ventilation removes the patient's own muscle-driven compensation and can acutely worsen hyperinflation, precipitating hypotension and cardiac arrest. Practical consequences: use the lowest possible respiratory rate, small tidal volumes, high inspiratory flow, and minimal PEEP, allow long expiratory times, and anticipate post-intubation hypotension - have fluids and vasopressors ready and disconnect from the ventilator briefly if the blood pressure crashes. This is why intubating an asthmatic is a high-risk procedure that should be done before, not after, complete exhaustion.
3. The patient improves with therapy and asks whether she can be given a β-blocker for her palpitations, since she takes a low-dose combined oral contraceptive and recently read about migraine prophylaxis. Address the pharmacologic reasoning.
Read the worked answer
Non-selective β-blockers are hazardous in asthma and should be avoided, because β2-receptors on bronchial smooth muscle mediate bronchodilation. Blocking them removes sympathetic bronchodilator tone and can precipitate severe bronchospasm, and the patient is already recovering from a near-fatal exacerbation. Propranolol is the classic offender; even ophthalmic timolol can cause bronchospasm, and cardioselective agents (metoprolol, atenolol) are only relatively safer and still carry risk at higher doses.
The reasoning to apply: distinguish β1 (cardiac - the target for palpitations/migraine prophylaxis) from β2 (bronchial, vascular, uterine). Selectivity is dose-dependent and lost at high doses. For her palpitations, first look for other causes - the sinus tachycardia here is likely a consequence of the exacerbation, β2-agonist use, and possibly fever/dehydration, all of which resolve with treatment.
If migraine prophylaxis is genuinely needed, choose an agent with no β-blocking action - for example amitriptyline or topiramate - rather than accepting bronchospasm risk. This is a case where the correct answer is to abandon the drug class rather than titrate within it.